No abstract available
MeSH terms
-
Bevacizumab / therapeutic use
-
Centers for Medicare and Medicaid Services, U.S. / standards*
-
Cetuximab / therapeutic use
-
Erlotinib Hydrochloride / therapeutic use*
-
Formularies as Topic / standards*
-
Humans
-
Medical Oncology / standards*
-
Neoplasms / drug therapy*
-
Off-Label Use / standards*
-
Protein Kinase Inhibitors / therapeutic use*
-
Review Literature as Topic
-
United States
Substances
-
Protein Kinase Inhibitors
-
Bevacizumab
-
Erlotinib Hydrochloride
-
Cetuximab